X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

EFTR

Closed

Effector Therapeutics Inc

0.0003
0.0000 (0.00%)
Last Update: 01 Jul 2025 18:56:00
Yesterday: 0.0003
Day's Range: 0.0002 - 0.0003
Send
When Written:
 
0.3527
Effector Therapeutics Inc is a biopharmaceutical company that focuses on developing novel small molecule drugs for the treatment of cancer. The company's proprietary technology platform, called eFFECTOR, targets specific cellular pathways that are critical for cancer cell survival and proliferation. Effector's lead drug candidate, eFT508, is a potent inhibitor of multiple cancer-causing pathways, including the MAPK and PI3K/AKT/mTOR pathways. The company is also developing other drugs that target specific cancer types and mutations, including KRAS-mutant cancers. Effector Therapeutics was founded in 2012 and is headquartered in San Diego, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X